[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]XIA C,DONG X,LI H,et al.Cancer statistics in China and United States,2022: profiles,trends,and determinants[J].Chin Med J(Engl),2022,135(5):584-590.
[3]AJANI JA,D'AMICO TA,BENTREM DJ,et al.Gastric cancer,version 2.2022,NCCN clinical practice guidelines in oncology[J].J Natl Compr Canc Netw,2022,20(2):167-192.
[4]CAVATORTA O,SCIDA S,MIRAGLIA C,et al.Epidemiology of gastric cancer and risk factors[J].Acta Bio-Medica:Atenei Parmensis,2018,89(8-S):82-87.
[5]GUO Y,LI ZX,ZHANG JY,et al.Association between lifestyle factors,vitamin and garlic supplementation,and gastric cancer outcomes:A secondary analysis of a randomized clinical trial[J].JAMA Netw Open,2020,3(6):e206628.
[6]MACHLOWSKA J,BAJ J,SITARZ M,et al.Gastric cancer:Epidemiology,risk factors,classification,genomic characteristics and treatment strategies[J].Int J Mol Sci,2020,21(11):4012.
[7]ZHOU Q,GUO J,HUANG W,et al.Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2[J].Mol Oncol,2020,14(9):2231-2250.
[8]ABUDUAINI R,MIAO X,XU J,et al.MicroRNA-194-3p inhibits the metastatic biological behaviors of spinal osteosarcoma cells by the repression of matrix metallopeptidase 9[J].Int J Clin Exp Pathol,2018,11(11):5257-5264.
[9]YI L,OUYANG L,WANG S,et al.Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1[J].J Cell Physiol,2019,234(10):19088-19102.
[10]LIU B,TIAN Y,CHEN M,et al.CircUBAP2 promotes MMP9-mediated oncogenic effect via sponging miR-194-3p in hepatocellular carcinoma[J].Front Cell Dev Biol,2021,9:675043.
[11]ARNOLD M,ABNET CC,NEALE RE,et al.Global burden of 5 major types of gastrointestinal cancer[J].Gastroenterology,2020,159(1):335-349.
[12]曹毛毛,李贺,孙殿钦,等.2000-2019年中国胃癌流行病学趋势分析[J].中华消化外科杂志,2021,20(1):102-109.
CAO MM,LI H,SUN DQ,et al.Epidemiological trend analysis of gastric cancer in China from 2000 to 2019[J].Chinese Journal of Gastroenterology,2021,20(1):102-109.
[13]BARTEL DP.MicroRNAs:target,recognition,and regulatory,functions[J].Cell, 2009,136(2):215-233.
[14]TU C.MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2[J].Cancer Letters,2013,335(1):219-224.
[15]GAO C,ZHANG Z,LIU W,et al.Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer[J].Cancer,2010,116(1):41-49.
[16]ZHANG XL,SHI HJ,WANG JP,et al.MiR-218 inhibits multidrug resistance(MDR) of gastric cancer cells by targeting Hedgehog/smoothened[J].Int J Clin Exp Pathol,2015,8(6):6397-6406.
[17]安艳新,赵青川.miRNA调控肿瘤多药耐药的研究进展[J].现代肿瘤医学,2017,25(17):2848-2851.
AN YX,ZHAO QC.Research advances of miRNA in regulating multidrug resistance of tumor[J].Modern Oncology,2017,25(17):2848-2851.